In last trading session, Silexion Therapeutics Corp (NASDAQ:SLXN) saw 0.41 million shares changing hands with its beta currently measuring 0.08. Company’s recent per share price level of $0.93 trading at $0.0 or 0.46% at ring of the bell on the day assigns it a market valuation of $8.12M. That closing price of SLXN’s stock is at a discount of -13020.43% from its 52-week high price of $122.02 and is indicating a premium of 38.71% from its 52-week low price of $0.57. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 7.02 million shares which gives us an average trading volume of 14.50 million if we extend that period to 3-months.
Silexion Therapeutics Corp (NASDAQ:SLXN) trade information
Upright in the green during last session for gaining 0.46%, in the last five days SLXN remained trading in the green while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $0.93 price level, adding 27.91% to its value on the day. Silexion Therapeutics Corp’s shares saw a change of -53.52% in year-to-date performance and have moved 24.57% in past 5-day. Silexion Therapeutics Corp (NASDAQ:SLXN) showed a performance of -19.46% in past 30-days. Number of shares sold short was 0.38 million shares which calculate 0.08 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -286.10% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 96.36% while estimates for its earnings growth in next 5 years are of 59.98%.
Silexion Therapeutics Corp (NASDAQ:SLXN)’s Major holders
Insiders are in possession of 5.98% of company’s total shares while institution are holding 7.18 percent of that, with stock having share float percentage of 7.64%. Investors also watch the number of corporate investors in a company very closely, which is 7.18% institutions for Silexion Therapeutics Corp that are currently holding shares of the company.
